CURATIVE BIOTECHNOLOGY INC
Profile
Company Names
CURATIVE BIOTECHNOLOGY INC
CONNECTYX TECHNOLOGIES CORP
Addresses
1825 NW CORPORATE BLVD, SUITE 110, BOCA RATON, FL 33431
3595 SW CORPORATE PARKWAY, PALM CITY, FL 34990
Phone Numbers
(561) 907-8990
800-526-8006
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER TECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
FLORIDA
Total Amount Raised:
$1,393,500.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-12-15
$146,000.00
$919,000.00
$773,000.00
Equity
2
2022-03-04
$1,000,000.00
$1,000,000.00
$0.00
Debt
1
2009-04-08
$247,500.00
$500,000.00
$252,500.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL
MICHAELS
EXECUTIVE OFFICER, DIRECTOR
INVESCO REAL ESTATE FUND III, L.P.
| 1000 MAIN REIT, LLC
| IREF III REIT, LLC
| INVESCO ICRE MASSACHUSETTS REIT HOLDINGS, LLC
| INVESCO ESC REAL ESTATE FUND III, L.P.
| INVESCO CORE REAL ESTATE - U.S.A , L.P.
| INVESCO U.S. INCOME FUND, L.P.
| INVESCO U.S. INCOME REIT, LLC
| INVESCO U.S. VALUE-ADD FUND IV, L.P.
| IREF IV REIT, LLC
| ICRE REIT HOLDINGS
| ICRE FEEDER FUND, L.P.
| INVESCO ESC U.S. VALUE-ADD FUND IV, L.P
| INVESCO U.S. VA FUND IV BLOCKER A, L.L.C.
| INVESCO U.S. VA PARALLEL FUND IV - 3, L.P
| INVESCO U.S. VA PARALLEL FUND IV - 2, L.P
| INVESCO U.S. VA PARALLEL FUND IV - 1, L.P.
| INVESCO U.S. VALUE-ADD FUND V, L.P.
| INVESCO COMMERCIAL MORTGAGE INCOME FUND, L.P.
| AXIS CMI REIT, LLC
| AXIS CMI FEEDER, L.P.
| CLO CMI BLOCKER, LLC
| CLO CMI FEEDER, L.P.
| INVESCO U.S. INCOME MASSACHUSETTS REIT HOLDINGS, LLC
| INVESCO CMI REIT, LLC
| INVESCO CORE REAL ESTATE - U.S.A., L.P.
| INVESCO VAF V FEEDER, LLC
| INVESCO STRATEGIC OPPORTUNITIES III, L.P.
| INVESCO STRATEGIC OPPORTUNITIES III ONSHORE FEEDER, LLC
| AISLE OPTICAL, INC.
| PANERA HOLDINGS CORP.
| CURATIVE BIOTECHNOLOGY INC
| PANERA BRANDS, INC.
CARY
SUCOFF
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2022-12-15
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Debt
2022-03-04
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE

